Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Delimobile opened new service stations

8/15/24 DELI

Sovcombank reported for 6 months of 2024 by IFRS

8/15/24 SVCB

Softline acquires control in one of Gazprombank's IT divisions

8/15/24 SOFL

Softline reported for 6 months of 2024 by IFRS

8/15/24 SOFL

VTB to join Post Bank in 2026

8/14/24 VTBR

Slavneft-Megionneftegaz reported for 6M 2024 by RAS

8/14/24 MFGS

Moscow Exchange resumes trading on the stock market

8/14/24 MOEX

Trading on the stock market has been suspended

8/14/24 MOEX

Fesco launches regular sea line between Vietnam and Malaysia

8/14/24 FESH

Board of Directors of Cherkizovo recommended dividends

8/14/24 GCHE